Inclusion Criteria:  newly diagnosed NSCLC histologically or cytologically proven stage III - IVA (oligometastatic) by complete staging ECOG 0-2 life expectancy 3 months ability to provide written informed consent  Exclusion Criteria:  primary resectability primary definitive chemoradiotherapy feasible